![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article 
Molecular and Cellular Biology, March 2008, p. 1702-1712, Vol. 28, No. 5
0270-7306/08/$08.00+0 doi:10.1128/MCB.01282-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
*
Agnieszka K. Rzadzinska,2,
Karen P. Steel,2 and
Allan Bradley1
Mouse Genomics,1 Genetics of Deafness Laboratories, The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom2
Received 17 July 2007/ Returned for modification 29 August 2007/ Accepted 15 December 2007
 |
ABSTRACT |
|---|
 Top ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Myosin VIIa is an unconventional myosin that, when lost or modified by mutation, is responsible for embryonic lethality and deafness in Drosophila melanogaster (26, 47), circling behavior in Mariner zebrafish mutants (11), hearing impairment and vestibular dysfunction in shaker1 mice, and hearing and retinal defects in human Usher syndrome 1B (13, 51). Myosin VIIa is expressed in sensory hair cells from the earliest stages of their development and localizes to their cytoplasm, apical parts, and stereocilia (15, 39). In mice homozygous for the Myo7a4626SB allele, an N-ethyl-N-nitrosourea-induced recessive nonsense mutation which reduces the protein to below detectable levels (13, 16, 32), bundles of stereocilia show progressive morphological rearrangements from around embryonic day 18.5 (21, 41). Kros and colleagues (28) previously described raised thresholds for transduction currents and abnormal transduction channel gating in hair cells of myosin VIIa mutants, which could be explained by a reduced tension of tip links, thus resulting in a deafness phenotype. This reduced gating spring tension could reflect the properties of the tip link complexes and, more generally, the overall morphological rearrangements within mutant hair bundles. The molecular mechanism for the disorganization of stereocilia within shaker1 hair bundles remains unresolved and could be related to insufficient stereocilia coupling within a bundle, defects in their anchoring into the cuticular plate, or a perturbed regulation of actin dynamics affecting elongation of stereocilia during development (40). The elucidation of the role(s) of myosin VIIa in hair bundle development is therefore crucial to enhance our understanding of the underlying basis for the deafness phenotypes of shaker1 mice and Usher 1B syndrome in humans.
Using an X-chromosome-directed bacterial artificial chromosome (BAC) transgenic approach, we demonstrate genetic complementation of the Myo7a4626SB allele (13, 16, 32). The embryonic stem (ES) cell-based BAC transgenesis method that we employed uses a recombination-mediated cassette exchange (RMCE) reaction whereby an "acceptor" locus of loxP and lox5-11 sites is targeted within the hypoxanthine-guanine phosphoribosyltransferase (Hprt) gene on the X chromosome to act as docking sites for an extrachromosomal DNA molecule with similarly arrayed lox sites (19, 43). Many BAC vectors used for creating genomic libraries have such an arrangement of lox sites (12, 52). The Hprt locus was chosen because it has proven to be a reliable integration site for expression from tissue-specific promoters (4, 14), including expression from a human BAC clone (18). Some previously described methods for the Cre-mediated integration of genomic constructs at a single loxP site (5) entail integration of the entire genomic construct, including the vector backbone. The inclusion of prokaryotic sequences in transgene constructs has been implicated in the silencing of their expression in mice (6, 8). The RMCE reaction described here minimizes prokaryotic sequences at the transgene integration site.
The Myo7a BAC transgenes integrated at the Hprt locus are subject to X inactivation so that Myo7a4626SB/4626SB females carrying a hemizygous copy of the transgene exhibit mosaic expression of myosin VIIa within the inner ear sensory epithelium. The fine mosaic of myosin VIIa-deficient and -complemented hair cells allowed a direct comparison of phenotypic differences between the two hair cell populations within the same specimen, thereby eliminating variables such as genetic background, sampling strategy, and parallel processing/analysis. When directly compared with their complemented counterparts, stereocilia lacking myosin VIIa are significantly longer but shorten faster in the presence of an actin polymerization inhibitor. In addition, the loss of whirlin from tips of stereocilia that normally occurs during hair bundle maturation was delayed, and this correlated with elevated levels of its immunofluorescence in myosin VIIa-deficient cells. Our results strongly suggest that myosin VIIa plays a regulatory role in setting the appropriate heights of stereocilia and demonstrate that X-linked BAC transgenic mouse lines provide a useful tool for studying gene function, as they can significantly enhance the resolution of phenotypic analyses.
|
MATERIALS AND METHODS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
tk) cassette (7) flanked by directionally opposed loxP and lox5-11 sites to create construct pCCI18; the 5' arm was a 2.5-kb EcoRV/HindIII fragment from vector pRIV6.9PGK, and the 3' arm was a 2.7-kb HindIII/BamHI fragment from vector pIV7.1 (17). Four BAC clones were used in this study: zebrafish (RPCI 71-30I22) and human (RPCI 11-189K21) BACs were used in the initial phase of establishing and validating BAC integration into ES cells, whereas BACs containing Myo7a (RPCI 23-138G2 and RPCI 24-233J11) were used for complementation in mice. The cloning vectors used in the four BAC clones, either pBACe3.6 or pTARBAC1, both contained loxP and lox5-11 sites flanking the genomic insert and the sacBII gene (12, 52). The vector backbones were modified by insertion of the pgk/EM7 Neo/KanR-positive selection cassette (pCEI1) into the sacBII gene by bacterial homologous recombination. pCEI1 was generated by PCR of homologous arms of sacBII sequences with Hi-Fidelity Supermix (Invitrogen) as follows: the 5' arm (bp 3110 to 3609) of pBACe3.6 was amplified with primers sacBII1A (AACGAAAAATACCAAGTGCCTCAA) and sacBII1B (GATATGTTTTTCCGTCTCCGTCAA), and the 3' arm (bp 3736 to 4179) of pBACe3.6 was amplified with primers sacBII3A (AAAACGGATACCAAGGCGAAGAATC) and sacBII 3B (CTGCGAAGTGAGAGTAAGTGAATG), followed by restriction enzyme digestion (HindIII/EcoRI for the 5' arm and SpeI/BamHI for the 3' arm) and four-way ligation into vector PL450 (31). The recombineering cassette was amplified by PCR using primers sacBII1A and sacBII3B and gel purified (Qiagen gel purification kit). BAC clones were modified in Escherichia coli EL350 cells (31). BAC clones were retransformed into E. coli DH10B cells for large-scale DNA preparation.
Recombination was confirmed by Southern analysis of BAC DNA using KanR gene- or homology arm-specific DNA probes. Additionally, for modification of sacBII, pulsed-field gel analysis was performed on 1 µg of NotI-digested BAC DNA using a Bio-Rad CHEF mapper (an initial switch time of 4 s, a final switch time of 17.3 s, a gradient of 6 V cm–1, and a run time of 18.3 h). A Qiagen large-construct kit was used for the preparation of modified BAC DNA. DNA was resuspended in Tris-EDTA buffer and concentrated by evaporation to approximately 1 µg ml–1.
ES cell culture. ES cell cultures, electroporation, mini-Southern-blot analysis of ES cell clones, and the generation of chimeric and germ line mice were described previously (37). The male 129S7/SvEvBrd-Hprt+ ES cell clone AB1 was used for targeting. ES cells (0.9 x 107 cells) were electroporated (500 µF, 230 V; Bio-Rad) with PmeI-linearized pCCI18 (10 µg) and selected after 24 h using puromycin (3 µg ml–1). Southern analysis was performed using a 5' external probe, a 400-bp BamHI/XmnI fragment isolated from clone RIV6.9IPGK, and a 3' external probe, a 0.7-kb HindIII/PstI fragment from clone phpt2 (17). The drug selection sensitivities of homologous recombinant hprttm(rmce1)Brd ES clones to hypoxanthine-aminopterin-thymidine, 6-thioguanine (6-TG), puromycin, and G418 were assessed.
For RMCE integration of BAC inserts into hprttm(rmce1)Brd, 3 x 107 cells were electroporated (500 µF, 230 V; Bio-Rad) with various amounts of BAC DNA and 25 µg pCAGGS-Cre (1). The selection of ES cell clones with G418 (200 µg ml–1) began 24 h after transfection and proceeded for 5 to 6 days. Subsequently, selection with 6-TG (10 µM) proceeded for 3 to 4 days, at which time double-resistant colonies were isolated. BAC integration was verified by Southern analysis using the 5' external probe and a 3' internal probe (400-bp EcoRI/XhoI fragment from clone IV7.1PGK) (17).
BAC integrity was analyzed by PCR under standard conditions (Platinum Taq; Invitrogen). Annealing temperatures were as follows: 50.0°C for RPCI 71-30I22 primer pairs 2, 5, and 7 and the mouse-specific control, 54.0°C for primer pairs 1, 3, 6, and 8, 58.0°C for primer pair 4, and 52.5°C for all RPCI 11-189K21 primer pairs. BAC integration was visualized by fluorescence in situ hybridization (FISH) analysis on metaphase spreads of ES cells (24). BAC probes were fluorescein isothiocyanate-labeled zebrafish (RPCI 71-30I22) and Texas Red-labeled mouse (RPCI 23-156G14) Hprt.
Mouse breeding and behavioral analyses. All animal studies were licensed by the United Kingdom Home Office under the Animals (Scientific Procedures) Act of 1986 and approved by the local ethics committee. To test for complementation, Myo7a4626SB/4626SB males were bred with Myo7a4626SB/+ Hprt(Myo7a)Brd/+ females. Offspring were of mixed CBA/Ca, 129S7, C3H, and C57BL/6J genetic backgrounds. Mice were genotyped by PCR for the Myo7a4626SB allele (21) and by Southern blotting with the Hprt 3' internal probe (see Appendix S1 in the supplemental material for an alternative PCR-based genotyping method for the BAC transgene). PCR-based genotyping does not determine the homozygosity of the Myo7a4626SB allele, as wild-type Myo7a is also present in BAC transgenic animals. Therefore, candidate complemented mice were selected based on the presence of BAC and the absence of a shaker1 vestibular phenotype. To confirm complementation, candidate BAC transgenic mice were test bred with wild-type C57BL/6J mice in order to establish whether they were Myo7a4626SB/4626SB based on the genotypes of offspring. Hearing was assessed using a Preyer's reflex (flick of the pinna) in response to a 19.5-kHz tone burst at an intensity of 90 dB sound pressure level, and vestibular function was evaluated based on behavior (circling, head bobbing, and hyperactive locomotion indicating vestibular dysfunction).
SEM. For scanning electron microscopy (SEM) analyses, cochleae from adult mice at postnatal day 28 (P28) were fixed for 3 h with 2.5% glutaraldehyde in 1 mM sodium cacodylate buffer (pH 7.4). Samples were then washed in phosphate-buffered saline, processed with the OTOTO (osmium-thiocarbohydrazide- osmium-thiocarbohydrazide-osmium) method, adapted from a method described previously by Hunter-Duvar (23), dehydrated in ethanol, critical-point dried (BalTec), and viewed with an S-4800 scanning electron microscope (Hitachi) at 3 to 5 kV. A summary of mice used for experimentation is provided in Appendix S2 in the supplemental material.
Histochemistry. Myosin VIIa was immunolocalized in cochleae isolated from mice at P5 and fixed in 4% paraformaldehyde using polyclonal anti-myosin VIIa antibody (Proteus BioSciences). Myosin XVa and whirlin were localized using antibodies PB48 and HL5141, respectively (3, 30), at P7, P15, and P28. Stereocilium dimensions and pixel intensity values (in arbitrary intensity units) were measured with NIH ImageJ software. Hair cells (10 to 30 cells for each genotype) from the middle turn of the cochlea were analyzed, and only the most lateral (tallest-row) stereocilia were evaluated (at least one cochlea of at least four animals of each genotype). Analyses of the dimensions of stereocilia were focused on the most lateral row, as it was not possible to unambiguously determine to which row the shorter stereocilia of the disorganized shaker1 hair bundles belonged. SEM images were obtained at the same distance from the detector and from samples mounted at comparable angles. Two-tailed t tests were performed using Excel software.
Organotypic cultures of mouse organ of Corti at P4 were prepared as previously described (39). For the cytochalasin D experiments, organ of Corti cultures from one ear were incubated for 16 h with Dulbecco's modified Eagle's F-12 medium containing 0.025 µM cytochalasin D from a 0.05 mM ethanol stock (Sigma), while the other ear of the same animal was incubated with an equivalent amount of ethanol (1.5 µl per 3 ml of medium). Cultures were then processed as previously described (39), and actin filaments were stained with Alexa Fluor 488/phalloidin and analyzed using a Zeiss LSM 510 confocal microscope (Zeiss) with a 63x 1.4-numerical-aperture objective.
A summary of mice used for experimentation is provided in Appendix S2 in the supplemental material.
Myo7a-lacZ mice. A full description of the generation and analysis of Myo7a-lacZ transcriptional reporter mice is contained in Appendix S7 in the supplemental material.
|
RESULTS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
red system (29, 31) was used to insert the kanamycin resistance gene into the sacBII gene present in the backbone of multiple vectors (Fig. 1c; see Appendix S3 in the supplemental material). A combination of G418 positive selection for integration of the BAC sequence followed by 6-TG negative selection for Hprt gene-specific integration can thus be employed to specifically select for the RMCE event (Fig. 1c).
|
|
BAC transgenesis and complementation of the shaker1 mutation. BAC clones from the C57BL/6J mouse strain containing the Myo7a gene (RPCI 23-138G2 and RPCI 24-233J11) were chosen for transgenesis (Fig. 3a). As a reporter for Myo7a transcription, RPCI 23-138G2 was modified by the integration of an E. coli lacZ gene. Analysis of the hprt(Myo7a-lacZ)Brd transgenic mouse line demonstrated that expression from the X chromosome within the inner ear was specifically in hair cells and persisted beyond 6 months of age (see Appendix S7 in the supplemental material). In order to complement the shaker1 phenotype of the Myo7a4626SB allele, a total of five transgenic mouse lines were created for two different Myo7a-containing BAC clones (see Appendix S8 in the supplemental material). From these five transgenic lines, two independent BAC transgenic lines for RPCI 23-138G2 (Myo7a BAC C11 and Myo7a BAC C9) and a single line for RPCI 24-233J11 (Myo7a BAC D7) were bred into the Myo7a mutant background. The breeding strategy culminated in a cross between a Myo7a4626SB/4626SB male and a Myo7a4626SB/+ female carrying the BAC transgene on an X chromosome so that half of the resulting offspring were expected to give a shaker1 phenotype in the absence of complementation. The offspring carrying at least one Myo7a4626SB allele and a BAC transgene, but showing no circling and head bobbing (indicative of vestibular dysfunction), were found in two out of three of the Myo7a BAC transgenic lines, namely, Myo7a BAC C11 and line Myo7a BAC D7, and complementation was confirmed by test breeding (see Appendix S9 in the supplemental material). Mice from both of these BAC transgenic lines were analyzed further, with the allele being collectively referred to as hprt(Myo7a)Brd. The third BAC transgenic line, Myo7a BAC C9, did not yield any complemented mice, presumably due to a deletion within the BAC that affected the normal function of the Myo7a gene.
|
|
The actin core of the mature stereocilium undergoes continuous turnover while its length is maintained in a dynamic steady state (39, 40). However, to promote elongation of stereocilia during development, the polymerization rates of actin filaments must exceed their depolymerization rates until the stereocilia reach their predetermined lengths. In the shaker1 mutants, the myosin VIIa deficiency within the cuticular plate (a dense, actin-rich structure at the apex of each hair cell) and at the bases of stereocilia could result in decreased rates of actin depolymerization and greater elongation of stereocilia. To investigate the rates of actin depolymerization in developing shaker1 hair bundles, we blocked actin polymerization with cytochalasin D (39) in cultured auditory epithelia harvested from P4 Myo7a4626SB/4626SB Hprt(Myo7a)Brd/+ females mosaic for myosin VIIa expression. In untreated explants from the corresponding regions of the other ear of each mouse, the myosin VIIa-deficient stereocilia of the lateral rows were significantly longer than the stereocilia of adjacent hair cells expressing myosin VIIa, consistent with our SEM observations of adult mice. However, upon 16 h of cytochalasin D treatment, the differences in lengths of stereocilia between myosin VIIa-deficient and -complemented hair cells were dramatically reduced (Fig. 4c and d), indicating that actin depolymerization rates were higher in the absence of myosin VIIa rather than lower.
The excessive elongation of myosin VIIa-deficient stereocilia could be explained by elevated rates of actin polymerization in the stereocilium core. Therefore, we analyzed the localization of two proteins implicated in elongation of stereocilia, myosin XVa and whirlin (3, 20, 27, 33), in myosin VIIa-deficient hair cells. Both myosin XVa and whirlin were found in the tips of both myosin VIIa-deficient and -complemented stereocilia at P7. The intensity of myosin XVa immunofluorescence was graded with stereocilium lengths, as previously described for control animals (39), while the intensities of whirlin labeling were comparable across the bundle of stereocilia (Fig. 5a) (3, 27). However, at P7, the whirlin-specific immunofluorescence measured at the level of the cuticular plate was elevated in hair cells lacking myosin VIIa compared to their complemented counterparts within mosaic epithelia (Fig. 5a). In Myo7a4626SB/+ mice, whirlin immunolabeling at the tips disappears from shorter stereocilia during morphological maturation of the bundle (3, 27). In myosin VIIa-complemented hair cells at P15 and P28, whirlin immunofluorescence recapitulated the distribution obtained previously with this antibody in wild-type adult mice and was observed only in the tips of the most lateral stereocilia of inner hair cells but was absent from the shorter stereocilia of the second and subsequent rows within the same bundle and from all outer hair cell stereocilia (Fig. 5a, top right). Surprisingly, however, whirlin immunoreactivity persisted across the mature bundles of stereocilia of both inner and outer hair cells lacking myosin VIIa at P15 and P28, irrespective of the length of individual stereocilia (Fig. 5a and data not shown). To further evaluate possible interactions between myosin VIIa and whirlin, we analyzed the spatial distribution of myosin VIIa within the auditory sensory epithelia of shaker2 and whirler mutants lacking myosin XVa and whirlin, respectively (2, 20, 33, 36). Although overall myosin VIIa-specific immunofluorescence showed comparable levels in the cytoplasms of mutant and control hair cells (data not shown), we detected myosin VIIa at the tips of the abnormally short stereocilia of both Whrnwi/wi and Myo15sh2/sh2 mice. In the lateral row of stereocilia of Whrnwi/+ and Myo15sh2/+ mice, the myosin VIIa labeling was restricted to the sides of stereocilia (Fig. 5b) and was absent from the tips, as previously described (15, 39). However, we were able to detect myosin VIIa in the tips of the shorter stereocilia within the same bundles of Whrnwi/+ and Myo15sh2/+ (Fig. 5b, inset) and wild-type (data not shown) mice.
|
|
DISCUSSION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
We envisage that the technique of RMCE integration of BACs could be particularly useful where control over copy number and integration site is desirable. One example might be the creation and phenotypic analysis of an allelic series of engineered transgene variants within mice or ES cells (38, 48). The minimal manipulation required also makes this approach an attractive alternative to targeted knock-in for creating transcriptional reporters or fusion proteins with a variety of tags and "humanizing" mice by gene addition on a null mutant background or by syntenic replacement (50).
X-inactivation mosaicism as a tool in cell biology research. Chimeras and mosaics provide a means to create mice containing two genetically distinct cell populations that can enhance the information on gene function that can be obtained from null mutant studies alone; for example, we can ask about the contribution of mutant cells to particular tissues during development or whether a gene functions cell autonomously (35, 46). Currently available strategies each have their own strengths and weaknesses. Chimeric expression always requires de novo production by fusing mutant and wild-type components as embryos or ES cells. Mice mosaic for a null allele can be achieved by the partial somatic inactivation of targeted endogenous floxed alleles by the use of appropriate Cre transgenic mouse lines. Alternatively, Cre-mediated mitotic recombination techniques have the potential to simultaneously create a mosaic null and fluorescently label the genotype (53). Mosaic expression through the epigenetic process of female X inactivation has previously been used in conjunction with phenotypically neutral reporter genes to trace cell lineages during development (9, 45). In this report, we extend the use of female X-inactivation mosaicism to study gene function using a simple and reliable method. A mouse line can be established with the appropriate temporal-spatial expression for a given gene in approximately half of the normal complement of cells. We demonstrate that this method has particular utility in comparative analyses. The mosaic inner ear epithelia used in this study allow us to evaluate two cell populations side by side so that immunolabeling with specific antibodies and quantitative analyses of stereocilial dimensions can be performed with minimal measurement error with respect to the developmental differences between individual animals, variable conditions of sample preparation, and, most importantly, the changing morphology of hair bundles along the cochlear duct. In the apical turn, V-shaped bundles are formed by relatively few but generally long stereocilia, while in the basal turn, the bundles are W-shaped bundles and are composed of more numerous and shorter stereocilia. The transition between these two extremes is gradual, giving intermediate lengths and numbers of stereocilia in the middle turn, so careful measurements of the cochlear duct are necessary if one wants to compare corresponding hair cells in two different animals. The importance of mosaic analyses is accentuated further in mouse mutants exhibiting abnormally short cochlear ducts (e.g., looptail) (34).
In future applications, the mosaic analysis may be facilitated by using reporter genes linked to the BAC transgene or to the other Hprt allele, thus providing a cell-autonomous marker for visualizing which cells are complemented. Alternatively, the ability to monitor the expression, or deficiency, of the complementing protein may be achieved by fusion to fluorescent proteins or an antibody epitope tag. In this report, hair cell pathology itself was predictive of myosin VIIa deficiency, and reliable antibodies were available, so additional cell-autonomous markers were not essential for the mosaic analysis.
Mosaic complementation demonstrates that myosin VIIa is involved in the dynamic regulation of elongation of stereocilia. The lengths of stereocilia and the staircase-like organization of the bundle are critical to the sensitivity of hair cells. Each stereocilium is supported by a rigid paracrystalline array of tightly cross-linked, parallel actin filaments, which undergoes continuous turnover so that the length of a mature stereocilium is maintained in a dynamic steady state (39). However, the molecular factors involved in the dynamic regulation of elongation of stereocilia and postdevelopmental maintenance of their length gradation within the staircase are yet to be defined. Here, we studied myosin VIIa, a positively oriented molecular motor expressed in hair cells that moves towards the plus ends of the actin filaments (49) at the stereocilial tips. The auditory sensory epithelium mosaic for myosin VIIa-deficient and -complemented hair cells demonstrated that stereocilia lacking myosin VIIa are longer than those of controls but shorten faster in the presence of an actin polymerization inhibitor. While our results obtained using cytochalasin D treatment disproved our working hypothesis that myosin VIIa has a role in promoting actin depolymerization at bases of stereocilia, they suggested the possibility of higher rates of actin polymerization in myosin VIIa-deficient stereocilia.
Our immunohistochemical analyses showed that both myosin XVa and whirlin, two proteins implicated in elongation of stereocilia (2, 3, 27, 40), localized to the tips of myosin VIIa-deficient stereocilia. However, myosin VIIa deficiency correlated with abnormally persistent whirlin localization in the tips of mature stereocilia of shorter rows, and this coincided with the higher intensity of whirlin-specific immunofluorescence in the hair cell cytoplasm. Most interestingly, we showed that myosin VIIa localized to the tips of the abnormally short stereocilia lacking whirlin or myosin XVa in Whrnwi/wi and Myo15sh2/sh2 mice (32, 36). In wild-type mice, whirlin is detectable at the tips of all stereocilia during development but only at the tips of the most lateral (tallest) stereocilia in adults. Conversely, myosin VIIa is absent from tips of developing control stereocilia (our unpublished observations) while being present at the tips of shorter mature stereocilia. It is striking that the stereocilial distributions of whirlin and myosin VIIa are mutually exclusive. This negative correlation between the tip localizations of whirlin and myosin VIIa indicates the presence of an interacting protein(s) that either stops myosin VIIa from binding to the tip complex during development of stereocilia or promotes myosin VIIa binding at the tips of mature stereocilia.
The tips of stereocilia show morphological variations. The most lateral (tallest) stereocilia have dome-shaped tips filled with electron-dense material, while the pointed tips of stereocilia from shorter rows show only small electron-dense patches. The extent of electron density correlates with the levels of myosin XVa immunoreactivity at the tips of stereocilia (39). It is possible that the myosin XVa/whirlin complexes promote actin polymerization in proportion to their densities and that myosin VIIa competes with the scaffold proteins at the tips, thus regulating the speed of actin polymerization. The lack of myosin XVa or whirlin would allow myosin VIIa molecules between the plasma membrane and actin paracrystal, as we have observed in the abnormally short stereocilia of Whrnwi/wi and Myo15sh2/sh2 mutant mice. Conversely, myosin VIIa deficiency would permit more whirlin molecules at the tips, resulting in abnormal elongation of stereocilia (Fig. 6). The lack of both whirlin and myosin VIIa would probably result in abnormally short stereocilia, as previously observed in shaker1/shaker2 double mutants (25), as the actin polymerization activity promoted by whirlin would be lost. The excessive elongation of myosin VIIa-deficient stereocilia would perturb the precision of their length gradation within a bundle, affecting the responses of hair cells to sound stimuli (44). Therefore, the dysregulation of the control of actin dynamics within stereocilia normally mediated by myosin VIIa is likely to be a major factor in the pathology of shaker1 in mice and Usher 1B in humans.
|
|
ACKNOWLEDGMENTS |
|---|
This work was supported by the Wellcome Trust, Medical Research Council, Deafness Research UK, and the European Commission (EuroHear LSHG-CT-2004-512063).
|
FOOTNOTES |
|---|
Published ahead of print on 26 December 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
H.M.P. and A.K.R. contributed equally to this article.
|
REFERENCES |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
2. Belyantseva, I. A., E. T. Boger, and T. B. Friedman. 2003. Myosin XVa localizes to the tips of inner ear sensory cell stereocilia and is essential for staircase formation of the hair bundle. Proc. Natl. Acad. Sci. USA 100:13958-13963.
3. Belyantseva, I. A., E. T. Boger, S. Naz, G. I. Frolenkov, J. R. Sellers, Z. M. Ahmed, A. J. Griffith, and T. B. Friedman. 2005. Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia. Nat. Cell Biol. 7:148-156.[CrossRef][Medline]
4. Bronson, S. K., E. G. Plaehn, K. D. Kluckman, J. R. Hagaman, N. Maeda, and O. Smithies. 1996. Single-copy transgenic mice with chosen-site integration. Proc. Natl. Acad. Sci. USA 93:9067-9072.
5. Call, L. M., C. S. Moore, G. Stetten, and J. D. Gearhart. 2000. A cre-lox recombination system for the targeted integration of circular yeast artificial chromosomes into embryonic stem cells. Hum. Mol. Genet. 9:1745-1751.
6. Chada, K., J. Magram, K. Raphael, G. Radice, E. Lacy, and F. Costantini. 1985. Specific expression of a foreign β-globin gene in erythroid cells of transgenic mice. Nature 314:377-380.[CrossRef][Medline]
7. Chen, Y. T., and A. Bradley. 2000. A new positive/negative selectable marker, putk, for use in embryonic stem cells. Genesis 28:31-35.[CrossRef][Medline]
8. Clark, A. J., G. Harold, and F. E. Yull. 1997. Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice. Nucleic Acids Res. 25:1009-1014.
9. Collinson, J. M., R. E. Hill, and J. D. West. 2004. Analysis of mouse eye development with chimeras and mosaics. Int. J. Dev. Biol. 48:793-804.[CrossRef][Medline]
10. DeRosier, D. J., and L. G. Tilney. 2000. F-actin bundles are derivatives of microvilli: what does this tell us about how bundles might form? J. Cell Biol. 148:1-6.
11. Ernest, S., G. J. Rauch, P. Haffter, R. Geisler, C. Petit, and T. Nicolson. 2000. Mariner is defective in myosin VIIA: a zebrafish model for human hereditary deafness. Hum. Mol. Genet. 9:2189-2196.
12. Frengen, E., D. Weichenhan, B. Zhao, K. Osoegawa, M. van Geel, and P. J. de Jong. 1999. A modular, positive selection bacterial artificial chromosome vector with multiple cloning sites. Genomics 58:250-253.[CrossRef][Medline]
13. Gibson, F., J. Walsh, P. Mburu, A. Varela, K. A. Brown, M. Antonio, K. W. Beisel, K. P. Steel, and S. D. Brown. 1995. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374:62-64.[CrossRef][Medline]
14. Guillot, P. V., L. Liu, J. A. Kuivenhoven, J. Guan, R. D. Rosenberg, and W. C. Aird. 2000. Targeting of human eNOS promoter to the Hprt locus of mice leads to tissue-restricted transgene expression. Physiol. Genomics 2:77-83.
15. Hasson, T., M. B. Heintzelman, J. Santos-Sacchi, D. P. Corey, and M. S. Mooseker. 1995. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc. Natl. Acad. Sci. USA 92:9815-9819.
16. Hasson, T., J. Walsh, J. Cable, M. S. Mooseker, S. D. Brown, and K. P. Steel. 1997. Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil. Cytoskel. 37:127-138.[CrossRef][Medline]
17. Hasty, P., J. Rivera-Perez, C. Chang, and A. Bradley. 1991. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol. Cell. Biol. 11:4509-4517.
18. Heaney, J. D., A. N. Rettew, and S. K. Bronson. 2004. Tissue-specific expression of a BAC transgene targeted to the Hprt locus in mouse embryonic stem cells. Genomics 83:1072-1082.[CrossRef][Medline]
19. Hoess, R. H., A. Wierzbicki, and K. Abremski. 1986. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res. 14:2287-2300.
20. Holme, R. H., B. W. Kiernan, S. D. Brown, and K. P. Steel. 2002. Elongation of hair cell stereocilia is defective in the mouse mutant whirler. J. Comp. Neurol. 450:94-102.[CrossRef][Medline]
21. Holme, R. H., and K. P. Steel. 2002. Stereocilia defects in waltzer (Cdh23), shaker1 (Myo7a) and double waltzer/shaker1 mutant mice. Hear. Res. 169:13-23.[CrossRef][Medline]
22. Hudspeth, A. J. 1985. The cellular basis of hearing: the biophysics of hair cells. Science 230:745-752.
23. Hunter-Duvar, I. M. 1978. A technique for preparation of cochlear specimens for assessment with the scanning electron microscope. Acta Otolaryngol. Suppl. 351:3-23.[Medline]
24. Hurst, C. D., H. Fiegler, P. Carr, S. Williams, N. P. Carter, and M. A. Knowles. 2004. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23:2250-2263.[CrossRef][Medline]
25. Karolyi, I. J., F. J. Probst, L. Beyer, H. Odeh, G. Dootz, K. B. Cha, D. M. Martin, K. B. Avraham, D. Kohrman, D. F. Dolan, Y. Raphael, and S. A. Camper. 2003. Myo15 function is distinct from Myo6, Myo7a and pirouette genes in development of cochlear stereocilia. Hum. Mol. Genet. 12:2797-2805.
26. Kiehart, D. P., J. D. Franke, M. K. Chee, R. A. Montague, T. L. Chen, J. Roote, and M. Ashburner. 2004. Drosophila crinkled, mutations of which disrupt morphogenesis and cause lethality, encodes fly myosin VIIA. Genetics 168:1337-1352.
27. Kikkawa, Y., P. Mburu, S. Morse, R. Kominami, S. Townsend, and S. D. Brown. 2005. Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium. Hum. Mol. Genet. 14:391-400.
28. Kros, C. J., W. Marcotti, S. M. van Netten, T. J. Self, R. T. Libby, S. D. Brown, G. P. Richardson, and K. P. Steel. 2002. Reduced climbing and increased slipping adaptation in cochlear hair cells of mice with Myo7a mutations. Nat. Neurosci. 5:41-47.[CrossRef][Medline]
29. Lee, E. C., D. Yu, J. Martinez de Velasco, L. Tessarollo, D. A. Swing, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.[CrossRef][Medline]
30. Liang, Y., A. Wang, I. A. Belyantseva, D. W. Anderson, F. J. Probst, T. D. Barber, W. Miller, J. W. Touchman, L. Jin, S. L. Sullivan, J. R. Sellers, S. A. Camper, R. V. Lloyd, B. Kachar, T. B. Friedman, and R. A. Fridell. 1999. Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2. Genomics 61:243-258.[CrossRef][Medline]
31. Liu, P., N. A. Jenkins, and N. G. Copeland. 2003. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13:476-484.
32. Mburu, P., X. Z. Liu, J. Walsh, D. Saw, Jr., M. J. Cope, F. Gibson, J. Kendrick-Jones, K. P. Steel, and S. D. Brown. 1997. Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct. 1:191-203.[Medline]
33. Mburu, P., M. Mustapha, A. Varela, D. Weil, A. El-Amraoui, R. H. Holme, A. Rump, R. E. Hardisty, S. Blanchard, R. S. Coimbra, I. Perfettini, N. Parkinson, A. M. Mallon, P. Glenister, M. J. Rogers, A. J. Paige, L. Moir, J. Clay, A. Rosenthal, X. Z. Liu, G. Blanco, K. P. Steel, C. Petit, and S. D. Brown. 2003. Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat. Genet. 34:421-428.[CrossRef][Medline]
34. Montcouquiol, M., R. A. Rachel, P. J. Lanford, N. G. Copeland, N. A. Jenkins, and M. W. Kelley. 2003. Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature 423:173-177.[CrossRef][Medline]
35. Nagy, A., and J. Rossant. 2001. Chimaeras and mosaics for dissecting complex mutant phenotypes. Int. J. Dev. Biol. 45:577-582.[Medline]
36. Probst, F. J., R. A. Fridell, Y. Raphael, T. L. Saunders, A. Wang, Y. Liang, R. J. Morell, J. W. Touchman, R. H. Lyons, K. Noben-Trauth, T. B. Friedman, and S. A. Camper. 1998. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science 280:1444-1447.
37. Ramirez-Solis, R., A. C. Davis, and A. Bradley. 1993. Gene targeting in embryonic stem cells. Methods Enzymol. 225:855-878.[Medline]
38. Roebroek, A. J., S. Reekmans, A. Lauwers, N. Feyaerts, L. Smeijers, and D. Hartmann. 2006. Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal development. Mol. Cell. Biol. 26:605-616.
39. Rzadzinska, A. K., M. E. Schneider, C. Davies, G. P. Riordan, and B. Kachar. 2004. An actin molecular treadmill and myosins maintain stereocilia functional architecture and self-renewal. J. Cell Biol. 164:887-897.
40. Schneider, M. E., I. A. Belyantseva, R. B. Azevedo, and B. Kachar. 2002. Rapid renewal of auditory hair bundles. Nature 418:837-838.[CrossRef][Medline]
41. Self, T., M. Mahony, J. Fleming, J. Walsh, S. D. Brown, and K. P. Steel. 1998. Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 125:557-566.[Abstract]
42. Slepecky, N. B., and Y. Ogata. 1996. Immunohistochemical labeling of inner ear tissues embedded in polyethylene glycol 4000—comparative study with araldite and unicryl embedded sections. Nippon Jibiinkoka Gakkai Kaiho 99:361-369.[Medline]
43. Soukharev, S., J. L. Miller, and B. Sauer. 1999. Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res. 27:e21.
44. Stepanyan, R., I. A. Belyantseva, A. J. Griffith, T. B. Friedman, and G. I. Frolenkov. 2006. Auditory mechanotransduction in the absence of functional myosin-XVa. J. Physiol. 576:801-808.
45. Stone, L. M., S. S. Tan, P. P. Tam, and T. E. Finger. 2002. Analysis of cell lineage relationships in taste buds. J. Neurosci. 22:4522-4529.
46. Tam, P. P., and J. Rossant. 2003. Mouse embryonic chimeras: tools for studying mammalian development. Development 130:6155-6163.
47. Todi, S. V., J. D. Franke, D. P. Kiehart, and D. F. Eberl. 2005. Myosin VIIA defects, which underlie the Usher 1B syndrome in humans, lead to deafness in Drosophila. Curr. Biol. 15:862-868.[CrossRef][Medline]
48. Toledo, F., C. W. Liu, C. J. Lee, and G. M. Wahl. 2006. RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses. Nucleic Acids Res. 34:e92.
49. Udovichenko, I. P., D. Gibbs, and D. S. Williams. 2002. Actin-based motor properties of native myosin VIIa. J. Cell Sci. 115:445-450.
50. Wallace, H. A., F. Marques-Kranc, M. Richardson, F. Luna-Crespo, J. A. Sharpe, J. Hughes, W. G. Wood, D. R. Higgs, and A. J. Smith. 2007. Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell 128:197-209.[CrossRef][Medline]
51. Weil, D., S. Blanchard, J. Kaplan, P. Guilford, F. Gibson, J. Walsh, P. Mburu, A. Varela, J. Levilliers, M. D. Weston, et al. 1995. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374:60-61.[CrossRef][Medline]
52. Zeng, C., N. Kouprina, B. Zhu, A. Cairo, M. Hoek, G. Cross, K. Osoegawa, V. Larionov, and P. de Jong. 2001. Large-insert BAC/YAC libraries for selective reisolation of genomic regions by homologous recombination in yeast. Genomics 77:27-34.[CrossRef][Medline]
53. Zong, H., J. S. Espinosa, H. H. Su, M. D. Muzumdar, and L. Luo. 2005. Mosaic analysis with double markers in mice. Cell 121:479-492.[CrossRef][Medline]
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||
